$11.700
-0.080 (-0.68%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PHAR por análisis de gráficos similares
Alphio's PHAR stock price prediction model matches the current Pharming Group NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.69 (-0.12%). The 1-week path is $11.22 (-4.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pharming Group NV?
Pharming Group NV (PHAR) is a good buy right now due to its current price of $1.10, which is significantly below the average analyst price target of $2.21, suggesting a potential upside of 101.33%. Additionally, despite a recent revenue estimate downgrade, the expected earnings per share for the full year has improved from $0.03 to $0.05, indicating potential profitability growth. The main risk is the forward P/E ratio of 277.78, which indicates high valuation expectations that may not be met if performance does not improve as anticipated.
PHAR cerró en $11.70 el Friday, tras bajar -0.68%
Pharming Group NV (PHAR) last closed at $11.7, losing -0.68%. These facts feed the 1-day and 1-week PHAR price prediction above.
Factores de la previsión
Los factores de la previsión de Pharming Group NV (PHAR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PHAR, ordenadas por similitud.
Análisis de estacionalidad de PHAR
Historically the probability of a positive August return for PHAR is 33.33%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PHAR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $11.19 | $13.71 | $15.29 | +17.21% |
| Sep 2026 | $7.47 | $10.24 | $11.03 | -12.46% |
| Oct 2026 | $10.21 | $10.37 | $13.00 | -11.40% |
| Nov 2026 | $11.69 | $11.94 | $11.95 | +2.01% |
| Dec 2026 | $9.43 | $10.15 | $11.40 | -13.27% |
En 2026, se proyecta que Pharming Group NV (PHAR) oscile entre $7.47 y $15.29.
Previsión mensual de Pharming Group NV para 2026
En Aug de 2026, se proyecta que Pharming Group NV promedie $13.71, con un mínimo de $11.19 y un máximo de $15.29.
En Sep de 2026, se proyecta que Pharming Group NV promedie $10.24, con un mínimo de $7.47 y un máximo de $11.03.
En Oct de 2026, se proyecta que Pharming Group NV promedie $10.37, con un mínimo de $10.21 y un máximo de $13.00.
En Nov de 2026, se proyecta que Pharming Group NV promedie $11.94, con un mínimo de $11.69 y un máximo de $11.95.
En Dec de 2026, se proyecta que Pharming Group NV promedie $10.15, con un mínimo de $9.43 y un máximo de $11.40.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.